CompletedNot Applicable

Doppler and Biological Second Trimester Placental Insufficiency Screening

France235 participantsStarted 2003-05

Plain-language summary

To assess the role of uterine artery and maternal serum leptin and lipids and their combination in screening for pre-eclampsia and small-for-gestational-age (SGA) fetuses at 20-24 weeks of gestation

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Chronic hypertension under medication * Diabetes * Thrombophilia * Previous history of pre-eclampsia * Previous history of unexplained stillbirth * Previous history of placental abruption * Previous history of SGA (\< 10th centile) * History of pre-eclampsia or chronic hypertension before 45 years in the mother or a sister * Obesity (BMI\>30) * Nulliparous after 40 years * Assisted conception with donor Exclusion Criteria: * Multiple pregnancy * Complicated pregnancy with a high probability of required fetal extraction before term * Pregnancy requiring termination * Unability to understand the study

Trial details

NCT IDNCT00465634

SponsorUniversity Hospital, Tours

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2007-06

View on ClinicalTrials.gov More Pre-Eclampsia trials